GI & Endoscopy

Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering, Seeking Alpha reports.

Theravance Biopharma Ireland and Janssen Biotech entered into a co-development and commercialization agreement over TD-1473, an inflammatory intestinal disease inhibitor.

The American Society for Metabolic and Bariatric Surgery added the intragastric balloon to its list of approved procedures and devices, effective Feb. 5.

A study in Inflammatory Bowel Diseases used a novel simulation model to assess the optimal treatment positioning for patients with moderately to severely active ulcerative colitis and to predict treatment response. The model supports the use of Entyvio as an…

Here are six updates on GI companies from the past week.

Jamison, Pa.-based Physicians Endoscopy is in the midst of celebrating its 20th anniversary.

Patrick Laing, MD, is a gastroenterologist at Walla Walla, Wash.-based Providence Gastroenterology.

Julie Tredemeyer, DO, joined the staff of Howard Regional Gastroenterology in Kokomo, Ind., the Kokomo Perspective reports.

New York City-based NYU Langone Health added Paul Oberstein, MD, to its staff, naming him director of gastrointestinal medical oncology and assistant director of its pancreatic cancer center.

A study, published in Cell Host & Microbe, discovered two types of bacteria that work cooperatively to trigger colon cancer tumors.